LysoBriteâ„¢ Red DND-99 |
22647-500Tests |
AAT Bioquest |
500 Tests |
EUR 166 |
Description: LysoBrite Red DND-99 is chemically same to the LysoTracker® Red DND-99 used for labeling and tracking acidic organelles in live cells (LysoTracker® is the trademark of ThermoFisher). |
Cusabio Laboratories manufactures the cac-nm-dnd-001 cusabio reagents distributed by Genprice. The Cac-Nm-Dnd-001 Cusabio reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Cusabio. Other Cac-Nm-Dnd-001 products are available in stock. Specificity: Cac-Nm-Dnd-001 Category: Cusabio
ICG 001 |
BPS Bioscience |
100 mg |
EUR 710 |
Description: CG001 is a small molecule inhibitor that targets Wnt/β-catenin pathway. It inhibits TCF/β-catenin mediated transcription by competing with β-catenin for CBP (CREB binding protein) but not p300 binding with an IC50 of 3 µM. It can be used to specifically evaluate the role of CBP/beta-catenin association on WNT signaling and cell physiology. |
ICG 001 |
BPS Bioscience |
25 mg |
EUR 330 |
Description: CG001 is a small molecule inhibitor that targets Wnt/β-catenin pathway. It inhibits TCF/β-catenin mediated transcription by competing with β-catenin for CBP (CREB binding protein) but not p300 binding with an IC50 of 3 µM. It can be used to specifically evaluate the role of CBP/beta-catenin association on WNT signaling and cell physiology. |
EPI-001 |
ApexBio |
10 mg |
EUR 157.2 |
Description: EPI-001 is a small-molecule inhibitor of androgen receptor N-terminal domain. EPI-001 could target the amino terminal domain of the AR and inhibit the protein-protein interactions which are necessary for AR transcriptional activity. |
EPI-001 |
ApexBio |
200 mg |
EUR 714 |
Description: EPI-001 is a small-molecule inhibitor of androgen receptor N-terminal domain. EPI-001 could target the amino terminal domain of the AR and inhibit the protein-protein interactions which are necessary for AR transcriptional activity. |
EPI-001 |
ApexBio |
50 mg |
EUR 351.6 |
Description: EPI-001 is a small-molecule inhibitor of androgen receptor N-terminal domain. EPI-001 could target the amino terminal domain of the AR and inhibit the protein-protein interactions which are necessary for AR transcriptional activity. |
TOK-001 |
ApexBio |
10 mg |
EUR 282 |
Description: TOK-001 (Galeterone) is a novel small molecule that selectively target CYP17 and androgen receptor for prostate cancer treatment [1]. |
Test Assays information
EPI-001 |
B6041-10 |
ApexBio |
10 mg |
EUR 157.2 |
Description: EPI-001 is a small-molecule inhibitor of androgen receptor N-terminal domain. EPI-001 could target the amino terminal domain of the AR and inhibit the protein-protein interactions which are necessary for AR transcriptional activity. |
EPI-001 |
B6041-200 |
ApexBio |
200 mg |
EUR 714 |
Description: EPI-001 is a small-molecule inhibitor of androgen receptor N-terminal domain. EPI-001 could target the amino terminal domain of the AR and inhibit the protein-protein interactions which are necessary for AR transcriptional activity. |
EPI-001 |
B6041-50 |
ApexBio |
50 mg |
EUR 351.6 |
Description: EPI-001 is a small-molecule inhibitor of androgen receptor N-terminal domain. EPI-001 could target the amino terminal domain of the AR and inhibit the protein-protein interactions which are necessary for AR transcriptional activity. |
TOK-001 |
A8623-10 |
ApexBio |
10 mg |
EUR 282 |
Description: TOK-001 (Galeterone) is a novel small molecule that selectively target CYP17 and androgen receptor for prostate cancer treatment [1]. |
TOK-001 |
A8623-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 199.2 |
Description: TOK-001 (Galeterone) is a novel small molecule that selectively target CYP17 and androgen receptor for prostate cancer treatment [1]. |
TOK-001 |
A8623-50 |
ApexBio |
50 mg |
EUR 714 |
Description: TOK-001 (Galeterone) is a novel small molecule that selectively target CYP17 and androgen receptor for prostate cancer treatment [1]. |
ICG 001 |
A8217-10 |
ApexBio |
10 mg |
EUR 211.2 |
Description: ICG001 is a small molecule inhibitor that targets Wnt/?-catenin pathway. It inhibits TCF/?-catenin mediated transcription by competing with ?-catenin for CBP (CREB binding protein) but not p300 binding with an IC50 of 3 µM [1]. |
ICG 001 |
A8217-100 |
ApexBio |
100 mg |
EUR 868.8 |
Description: ICG001 is a small molecule inhibitor that targets Wnt/?-catenin pathway. It inhibits TCF/?-catenin mediated transcription by competing with ?-catenin for CBP (CREB binding protein) but not p300 binding with an IC50 of 3 µM [1]. |
ICG 001 |
A8217-25 |
ApexBio |
25 mg |
EUR 412.8 |
Description: ICG001 is a small molecule inhibitor that targets Wnt/?-catenin pathway. It inhibits TCF/?-catenin mediated transcription by competing with ?-catenin for CBP (CREB binding protein) but not p300 binding with an IC50 of 3 µM [1]. |
ICG 001 |
A8217-5 |
ApexBio |
5 mg |
EUR 151.2 |
Description: ICG001 is a small molecule inhibitor that targets Wnt/?-catenin pathway. It inhibits TCF/?-catenin mediated transcription by competing with ?-catenin for CBP (CREB binding protein) but not p300 binding with an IC50 of 3 µM [1]. |
ICG 001 |
A8217-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 212.4 |
Description: ICG001 is a small molecule inhibitor that targets Wnt/?-catenin pathway. It inhibits TCF/?-catenin mediated transcription by competing with ?-catenin for CBP (CREB binding protein) but not p300 binding with an IC50 of 3 µM [1]. |
ICG 001 |
A8217-S |
ApexBio |
Evaluation Sample |
EUR 97.2 |
Description: ICG001 is a small molecule inhibitor that targets Wnt/?-catenin pathway. It inhibits TCF/?-catenin mediated transcription by competing with ?-catenin for CBP (CREB binding protein) but not p300 binding with an IC50 of 3 µM [1]. |
ICG-001 |
E1KS2662 |
EnoGene |
5mg1 PHYSICAL AND CHEMICAL PROPERTIES |
EUR 625.2 |
Rabbit anti-CAC Antibody |
DL98095A-100ul |
DL Develop |
100 ul |
EUR 325 |
|
Description: CAC; CACT; Mitochondrial carnitine/acylcarnitine carrier protein; Carnitine/acylcarnitine translocase; CAC; Solute carrier family 25 member 20 |